Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Hospital variation in neonatal echocardiography among very preterm infants at US children’s hospitals

Abstract

Objective

Estimate hospital variation in echocardiography (echo) among very preterm infants.

Study design

Retrospective cohort study of very preterm (<32 weeks) infants discharged between 2012 and 2019 from US children’s hospitals. Echo exposure was identified using daily billing, and hospital variation was estimated after adjustment for illness severity. Variation in very early echo use (<3 days of life) was compared to exposure to treatment of a patent ductus arteriosus (PDA), and other practice patterns.

Results

27,498 subjects across 39 children’s hospitals were included. Very early echo use had the greatest hospital variation (3–34%). Increasing very early echo use was not associated with PDA treatment (p = 0.93), but was associated with nitric oxide (p < 0.01) and vasoactive medications (p < 0.01).

Conclusions

Hospital variation in echo use among preterm infants was greatest in the first few days of life and was associated with increasing nitric oxide and vasoactive medication use. The impact of this variation on clinical outcomes is uncertain and warrants further investigation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Hospital variation in timing of initial echocardiography.
Fig. 2: Hospital variation in the average age of initial echocardiography.
Fig. 3: Association between the percentage of infants receiving a very early echo (<3 days of life) and echo-related costs per 100 patients at included children’s hospitals.
Fig. 4: Association between the percentage of infants receiving a very early echo (<3 days of life) and selected early treatment exposures.

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.

References

  1. Berwick DM. Avoiding overuse—the next quality frontier. Lancet. 2017;390:102–4.

    Article  Google Scholar 

  2. Goodman DC. Unwarranted Variation in Pediatric Medical Care. Pediatr Clin North Am. 2009;56:745–55.

    Article  Google Scholar 

  3. Wennberg JE. Unwarranted variations in healthcare delivery: implications for academic medical centres. Br Med J. 2002;325:961–4.

    Article  Google Scholar 

  4. Goodman DC, Ganduglia-Cazaban C, Franzini L, Stukel TA, Wasserman JR, Murphy MA, et al. Neonatal Intensive Care Variation in Medicaid-Insured Newborns: a population-based study. J Pediatr. 2019;209:44–51.

    Article  Google Scholar 

  5. Slaughter JL, Stenger MR, Reagan PB. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia. Pediatrics. 2013;131:716–23.

    Article  Google Scholar 

  6. Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children’s Hospitals. J Pediatr. 2016;174:63–70.

    Article  CAS  Google Scholar 

  7. Stenger MR, Slaughter JL, Kelleher K, Shepherd EG, Klebanoff MA, Reagan P, et al. Hospital variation in nitric oxide use for premature infants. Pediatrics. 2012;129:945–51.

    Article  Google Scholar 

  8. Adams M, Bassler D, Bucher HU, Roth-Kleiner M, Berger TM, Braun J, et al. Variability of very low birth weight infant outcome and practice in swiss and US neonatal units. Pediatrics. 2018;141:e20173436.

    Article  Google Scholar 

  9. Alleman BW, Bell EF, Li L, Dagle JM, Smith PB, Ambalavanan N, et al. Individual and center-level factors affecting mortality among extremely low birth weight infants. Pediatrics. 2013;132:e175–84.

    Article  Google Scholar 

  10. Pierrat V, Burguet A, Marchand-Martin L, Cambonie G, Coquelin A, Roze JC, et al. Variations in patterns of care across neonatal units and their associations with outcomes in very preterm infants: the French EPIPAGE-2 cohort study. BMJ Open. 2020;10:e035075.

    Article  Google Scholar 

  11. King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Hall M, et al. Prioritization framework for improving the value of care for very low birth weight and very preterm infants. J Perinatol. 2021;41:2463–73.

    Article  Google Scholar 

  12. King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Patrick SW, et al. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol. 2020;41:295–304.

    Article  Google Scholar 

  13. Sankar MN, Bhombal S, Benitz WE. PDA: to treat or not to treat. Congenit Heart Dis. 2019;14:46–51.

    Article  Google Scholar 

  14. Soll RF. Inhaled nitric oxide for preterm infants: what can change our practice? Pediatrics. 2018;141:e20174214.

    Article  Google Scholar 

  15. O’Byrne ML, Millenson ME, Grady CB, Huang J, Bamat NA, Munson DA, et al. Trends in transcatheter and operative closure of patent ductus arteriosus in neonatal intensive care units: Analysis of data from the Pediatric Health Information Systems Database. Am Heart J. 2019;217:121–30.

    Article  Google Scholar 

  16. Goodman D, Little G, Harrison W, Moen A, Mowitz M, Ganduglia-Cazaban C. (eds). The Dartmouth Atlas of Neonatal Intensive Care. The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, 2019.

  17. EL-Khuffash A, Bussmann N, Breatnach CR, Smith A, Tully E, Griffin J, et al. A Pilot Randomized Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score (The PDA RCT). J Pediatr. 2021;229:127–33.

    Article  CAS  Google Scholar 

  18. EL-Khuffash A, James AT, Corcoran JD, Dicker P, Franklin O, Elsayed YN, et al. A Patent Ductus Arteriosus Severity Score Predicts Chronic Lung Disease or Death before Discharge. J Pediatr. 2020;167:1354–61.

    Article  Google Scholar 

  19. Rozé JC, Cambonie G, Marchand-Martin L, Gournay V, Durrmeyer X, Durox M, et al. Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm infants. J Am Med Assoc. 2015;313:2441–8.

    Article  Google Scholar 

  20. Demauro SB, Cohen MS, Ratcliffe SJ, Abbasi S, Schmidt B. Serial echocardiography in very preterm infants: a pilot randomized trial. Acta Paediatr Int J Paediatr. 2013;102:1048–53.

    Google Scholar 

  21. Isayama T, Kusuda S, Adams M, Berti E, Battin M, Al E. International Variation in the Management of Patent Ductus Arteriosus and Its Association with Infant Outcomes: a survey and linked cohort study. J Pediatr. 2022;244:24–9.

    Article  Google Scholar 

  22. Bussmann N, Smith A, Breatnach CR, McCallion N, Cleary B, Franklin O, et al. Patent ductus arteriosus shunt elimination results in a reduction in adverse outcomes: a post hoc analysis of the PDA RCT cohort. J Perinatol. 2021;41:127–33.

    Article  Google Scholar 

  23. Hundscheid T, Donders R, Onland W, Kooi EMW, Vijlbrief DC, de Vries WB, et al. Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan. Trials. 2021;22:1–12.

    Article  Google Scholar 

  24. Bell JL, Gupta S, Juszczak E, Hardy P, Linsell L. Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes. Trials. 2021;22:1–13.

    Google Scholar 

  25. De Buyst J, Rakza T, Pennaforte T, Johansson AB, Storme L. Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus. J Pediatr. 2012;161:404–8.

    Article  Google Scholar 

  26. Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2017;1:CD000509.

    Google Scholar 

  27. Ahmed MS, Giesinger RE, Ibrahim M, Baczynski M, Louis D, McNamara KP, et al. Clinical and echocardiography predictors of response to inhaled nitric oxide in hypoxic preterm neonates. J Paediatr Child Health. 2019;55:753–61.

    Google Scholar 

  28. Papadhima I, Louis D, Purna J, Deshpande P, Diambomba Y, Lee S, et al. Targeted neonatal echocardiography (TNE) consult service in a large tertiary perinatal center in Canada. J Perinatol. 2018;38:1039–45.

    Article  Google Scholar 

  29. Alammary D, Narvey M, Soni R, Elsayed Y, Louis D. Targeted neonatal echocardiography service in neonatal intensive care in Manitoba, Canada. J Perinatol. 2021;42:655–9.

  30. Harabor A, Soraisham AS. Utility of targeted neonatal echocardiography in the management of neonatal illness. J Ultrasound Med. 2015;34:1259–63.

    Article  Google Scholar 

  31. El-Khuffash A, Herbozo C, Jain A, Lapointe A, Mcnamara PJ. Targeted neonatal echocardiography (TnECHO) service in a Canadian neonatal intensive care unit: a 4-year experience. J Perinatol. 2013;33:687–90.

    Article  CAS  Google Scholar 

  32. Giesinger RE, Stanford AH, Rios DR, Bhombal S, Fraga MV, Levy VY, et al. Targeted neonatal echocardiography in the United States of America: the contemporary perspective and challenges to implementation. Pediatr Res 2019 857. 2019;85:919–21.

    Google Scholar 

  33. Shwartz M, Young DW, Siegrist R. The ratio of costs to chargees: how good a basis for estimating costs? Inquiry. 1995;32:476–81.

    Google Scholar 

  34. Phibbs CS, Schmitt SK, Cooper M, Gould JB, Lee HC, Profit J, et al. Birth Hospitalization Costs and Days of Care for Mothers and Neonates in California, 2009-11. J Pediatr. 2019;204:118–25.

    Article  Google Scholar 

  35. Russell RB, Green NS, Steiner CA, Meikle S, Howse JL, Poschman K, et al. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics. 2007;120:e1–9.

    Article  Google Scholar 

  36. Hay S, Mowitz M, Dukhovny D, Viner C, Levin J, King B, et al. Unbiasing costs? An appraisal of economic assessment alongside randomized trials in neonatology. Semin Perinatol. 2021;45:151391.

    Article  Google Scholar 

Download references

Funding

American Academy of Pediatrics—Marshall Klaus Perinatal Research Award.

Author information

Authors and Affiliations

Authors

Contributions

All authors gave final approval of the version to be published. All authors agree to be accountable for all aspects of the work. Conceptualization/design/methodology: BCK, TR, JB, JS, JH. Investigation/formal analysis: BCK, TR, JB, JS, JH. Ppaer drafting: BCK, JS. Paper editing: BCK, TR, JB, JS, JH.

Corresponding author

Correspondence to Brian C. King.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

King, B.C., Hagan, J., Richardson, T. et al. Hospital variation in neonatal echocardiography among very preterm infants at US children’s hospitals. J Perinatol 43, 181–186 (2023). https://doi.org/10.1038/s41372-022-01522-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-022-01522-2

This article is cited by

Search

Quick links